FDA Issues Safety Alert for COVID-19 Test Over Concerns of False Results
In the safety communication, the FDA noted that the use of this unauthorized test may increase the risk of false results.
COVID19
MPR Weekly Dose Podcast Episode 115
Treatment approved for hospitalized COVID patients; Update on Varenicline; Limits have been set for the Janssen vaccine; weekly dose podcast!
Olumiant Approved for COVID-19 Treatment in Hospitalized Adults
The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
Rare Cases of COVID-19 Relapse Seen With Pfizer Pill
Reports of symptoms returning in patients several days after completing the five-day regimen of Paxlovid
Dapagliflozin Does Not Improve Kidney Outcomes in Hospitalized COVID-19 Cases
Investigators report findings from a secondary analysis of the DARE-19 trial, which compared dapagliflozin with placebo in patients hospitalized with COVID-19.
April 2022: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in April 2022 for investigational products in development.
COVID-19 Drug Paxlovid Might Also Fight Long COVID
Series of case reports shows some success with Paxlovid in treating patients with long COVID
New BA.2 COVID-19 Subvariant Taking Hold in United States
Early research suggests that BA.2.12.1 is better able to evade the immune system than previous versions of the coronavirus
Plant-Based Recombinant COVID-19 Vaccine Found to Be Effective
Vaccine efficacy ranged from 69.5 percent against symptomatic infection to 78.8 percent against moderate-to-severe disease
FDA Warns of Counterfeit Home COVID-19 Test Kits
Two fakes the FDA knows of are counterfeit Flowflex COVID-19 test kits and iHealth Antigen Rapid Test Kits
